Paroxysmal Nocturnal Haemoglobinuria (Accredited)

 

Programme objective: Laboratories are requested to report the percentage of PNH erythrocytes (total, type II and type III) and the total clone size as a percentage for both PNH neutrophils and PNH monocytes in each sample. Additionally, they are asked to record whether a clone is present or absent. If a cell population is not routinely tested, then this option must be selected. Participants are also requested to provide information relating to gating and GPI linked antibodies and should also state their level of sensitivity for the assay for each cell population analysed.

 

Clinical/scientific background: PNH is an acquired stem cell disorder affecting all blood cell lines that has severe implications to both the life expectancy and quality of life affected individuals. In addition, treatment of the disorder is expensive. For these reasons PNH testing by flow cytometry is classed as a critical clinical diagnostic test.

 

Suitability: These samples are suitable for flow cytometric analysis only, and they are not suitable for those who use other detection methods such as gel cards.

 

Sample type/distribution: The programme issues two samples per trial, these are of stabilised whole blood into which stabilised PNH material may be spiked to create PNH Clone Present samples, PNH Clone Absent samples are also issued. This programme issues samples a minimum of 5 times per annum and a maximum of 6.A trial schedule may be found here https://www.ukneqasli.co.uk/eqa-pt-programmes/trial-schedules/

 

Trial duration: Trials for this programme are live/open for 3 weeks. Please note, trials issued/closing in August or December are extended by 1 week. An automated email is sent 2 days prior to the trial closing, to any participant that has not returned results, warning them of the trial closure date.

 

Subcontracted areas: Pre-issue testing of samples for this programme are subcontracted to an approved accredited laboratory.

 

Updates to the programme for current or upcoming year: Further electronic exercises to be issued.

 

To register for this programme, please click here.

Example Paroxysmal Nocturnal Haemoglobinuria Report
To view the annotations on this report, please download the PDF and view in a PDF reader such as Adobe Acrobat.
PNH 222302 annotated.pdf
Adobe Acrobat document [1.4 MB]
Paroxysmal Nocturnal Haemoglobinuria Performance Monitoring System
Performance Monitoring System for PNH.pd[...]
Adobe Acrobat document [107.4 KB]
PNH 242505 Coversheet
PNH 242505.pdf
Adobe Acrobat document [263.9 KB]
Print | Sitemap

Follow Us Online
Facebook Twitter LinkedIn Youtube

Disclaimer

Last updated 16/10/2024 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.

This website uses cookies. For more information please click here.


Please click here for our privacy policy.


The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).